Steven D. Harr
2022 - Sana Biotechnology
In 2022, Steven D. Harr earned a total compensation of $3.8M as President, Chief Executive Officer, and Director at Sana Biotechnology, a 221% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $389,063 |
|---|---|
| Option Awards | $2,770,084 |
| Salary | $644,832 |
| Other | $4,000 |
| Total | $3,807,978 |
Harr received $2.8M in option awards, accounting for 73% of the total pay in 2022.
Harr also received $389.1K in non-equity incentive plan, $644.8K in salary and $4K in other compensation.
Rankings
In 2022, Steven D. Harr's compensation ranked 919th out of 5,501 executives tracked by ExecPay. In other words, Harr earned more than 83.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 919 out of 5,501 | 83rd |
Division Manufacturing | 419 out of 2,980 | 86th |
Major group Chemicals And Allied Products | 150 out of 1,335 | 89th |
Industry group Drugs | 136 out of 1,238 | 89th |
Industry Biological Products, Except Diagnostic Substances | 32 out of 287 | 89th |
Source: SEC filing on April 28, 2023.
Harr's colleagues
We found two more compensation records of executives who worked with Steven D. Harr at Sana Biotechnology in 2022.
News
Sana Biotechnology Former Executive Vice President and President, Research and Development Douglas Williams receives $3M in 2023
April 26, 2024
Sana Biotechnology General Counsel Bernard Cassidy receives $4M in 2022
April 28, 2023
Sana Biotechnology Chief Medical Officer Sunil Agarwal receives $1.9M in 2021
April 26, 2022